In last trading session, ChromaDex Corporation (NASDAQ:CDXC) saw 0.15 million shares changing hands with its beta currently measuring 1.69. Company’s recent per share price level of $1.70 trading at $0.0 or 0.00% at ring of the bell on the day assigns it a market valuation of $131.90M. That closing price of CDXC’s stock is at a discount of -200.0% from its 52-week high price of $5.10 and is indicating a premium of 32.35% from its 52-week low price of $1.15. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.34 million shares which gives us an average trading volume of 270.63K if we extend that period to 3-months.
ChromaDex Corporation (NASDAQ:CDXC) trade information
CDXC remained trading in the red while hitting it’s week-highest on Thursday, 11/17/22 when the stock touched $1.70 price level, adding 6.08% to its value on the day. ChromaDex Corporation’s shares saw a change of -54.55% in year-to-date performance and have moved -3.41% in past 5-day. ChromaDex Corporation (NASDAQ:CDXC) showed a performance of 18.88% in past 30-days. Number of shares sold short was 2.02 million shares which calculate 8.04 days to cover the short interests.
ChromaDex Corporation (CDXC) estimates and forecasts
Statistics highlight that ChromaDex Corporation is scoring comparatively higher than the scores of other players of the relevant industry. Apart from that, the company came raising its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to increase by 53.80% in the current quarter and calculating 50.00% increase in the next quarter. This year revenue growth is estimated to rise 7.80% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $18.69 million for the same. And 6 analysts are in estimates of company making revenue of $20.04 million in the next quarter that will end on Dec 2022. Company posted $17.31 million and $17.76 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 8.00% while estimating it to be 12.80% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -33.50% during past 5 years.
ChromaDex Corporation is more likely to be releasing its next quarterly report on November 02 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
ChromaDex Corporation (NASDAQ:CDXC)’s Major holders
Insiders are in possession of 45.13% of company’s total shares while institution are holding 20.67 percent of that, with stock having share float percentage of 37.68%. Investors also watch the number of corporate investors in a company very closely, which is 20.67% institutions for ChromaDex Corporation that are currently holding shares of the company. Yong Rong (HK) Asset Management Ltd is the top institutional holder at CDXC for having 2.71 million shares of worth $4.52 million. And as of Jun 29, 2022, it was holding 3.96% of the company’s outstanding shares.
The second largest institutional holder is Tieton Capital Management, LLC, which was holding about 2.29 million shares on Jun 29, 2022. The number of shares represents firm’s hold over 3.34% of outstanding shares, having a total worth of $3.82 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 1.34 million shares of worth $2.23 million or 1.96% of the total outstanding shares. The later fund manager was in possession of 0.74 million shares on Jun 29, 2022, making its stake of worth around $1.24 million in the company or a holder of 1.09% of company’s stock.